Trial Profile
MoLO study - Evaluation of cost/efficacy ratio of monotherapy with lopinavir/ritonavir versus standard in patients treated with protease inhibitors in virologic suppressison.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 30 Sep 2013
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Abacavir; Atazanavir; Darunavir; Efavirenz; Emtricitabine; HIV protease inhibitors; Lamivudine; Nevirapine; Nucleoside reverse transcriptase inhibitors; Ritonavir; Saquinavir; Stavudine; Tenofovir disoproxil fumarate; Tipranavir; Zidovudine
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms MoLO
- 28 Aug 2011 New trial record